title: Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells.
abstract: Whether stromal components facilitate growth, invasion, and dissemination of cancer cells or suppress neoplastic lesions from further malignant progression is a continuing conundrum in tumor biology. Conceptualizing a dynamic picture of tumorigenesis is complicated by inter-individual heterogeneity. In the post genomic era, unraveling such complexity remains a challenge for the cancer biologist. Towards establishing a functional association between cellular crosstalk and differential cancer aggressiveness, we identified a signature of malignant breast epithelial response to stromal signaling. Proximity to fibroblasts resulted in gene transcript alterations of >2-fold for 107 probes, collectively designated as Fibroblast Triggered Gene Expression in Tumor (FTExT). The hazard ratio predicted by the FTExT classifier for distant relapse in patients with intermediate and high grade breast tumors was significant compared to routine clinical variables (dataset 1, n = 258, HR--2.11, 95% CI 1.17-3.80, p-value 0.01; dataset 2, n = 171, HR--3.07, 95% CI 1.21-7.83, p-value 0.01). Biofunctions represented by FTExT included inflammatory signaling, free radical scavenging, cell death, and cell proliferation. Unlike genes of the 'proliferation cluster', which are overexpressed in aggressive primary tumors, FTExT genes were uniquely repressed in such cases. As proof of concept for our correlative findings, which link stromal-epithelial crosstalk and tumor behavior, we show a distinctive differential in stromal impact on prognosis-defining functional endpoints of cell cycle progression, and resistance to therapy-induced growth arrest and apoptosis in low vs. high grade cancer cells. Our experimental data thus reveal aspects of 'paracrine cooperativity' that are exclusively contingent upon the histopathologically defined grade of interacting tumor epithelium, and demonstrate that epithelial responsiveness to the tumor microenvironment is a deterministic factor underlying clinical outcome. In this light, early attenuation of epithelial-stromal crosstalk could improve the management of cases prone to be clinically challenging.
authors.affiliation: California Pacific Medical Center Research Institute, San Francisco, California, United States of America.
authors.forename: Maria Gloria
authors.initials: MG
authors.lastname: Luciani
authors.forename: Junhee
authors.initials: J
authors.lastname: Seok
authors.forename: Aejaz
authors.initials: A
authors.lastname: Sayeed
authors.forename: Stacey
authors.initials: S
authors.lastname: Champion
authors.forename: William H
authors.initials: WH
authors.lastname: Goodson
authors.forename: Stefanie S
authors.initials: SS
authors.lastname: Jeffrey
authors.forename: Wenzhong
authors.initials: W
authors.lastname: Xiao
authors.forename: Michael
authors.initials: M
authors.lastname: Mindrinos
authors.forename: Ronald W
authors.initials: RW
authors.lastname: Davis
authors.forename: Shanaz H
authors.initials: SH
authors.lastname: Dairkee
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D002453:Cell Cycle; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D011230:Precancerous Conditions / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction; D017154:Stromal Cells / Q000378:metabolism*